Infographics

The Prompt-HF Trial Infographic

PROMPT-HF: Electronic Alerts to Improve Heart Failure Therapy in Outpatient Practice The PROMPT-HF trial tested the effectiveness of electronic medical record (EMR) alerts in improving the prescription of guideline-directed medical therapy (GDMT) for heart failure with reduced ejection fraction (HFrEF). Results indicated that these alerts significantly increased GDMT prescription rates,…

Continue ReadingThe Prompt-HF Trial Infographic

The Empulse Trial Infographic

EMPULSE: Empagliflozin in Patients Hospitalized for Acute Heart Failure EMPULSE assessed the effects of empagliflozin, an SGLT2 inhibitor, on patients hospitalized for acute heart failure (AHF). The study showed that empagliflozin significantly improved clinical outcomes, survival, and quality of life for patients hospitalized with AHF, regardless of baseline physical impairment,…

Continue ReadingThe Empulse Trial Infographic

The DIAMOND Study Infographic

The DIAMOND Study: Patiromer for the Management of Hyperkalemia in Subjects Receiving RAASi for HFrEF Summary:This study evaluated the role of Patiromer in enabling patients with heart failure with reduced ejection fraction (HFrEF) and hyperkalemia to maintain optimal RAAS inhibitor therapy. The findings suggested that Patiromer allowed patients to stay…

Continue ReadingThe DIAMOND Study Infographic

2022 AHA/ACC/HFSA Heart Failure Management Guidelines – Value Statements

2022 AHA/ACC/HFSA Heart Failure Management Guidelines - Value Statements This infographic outlines the economic value statements from the 2022 AHA/ACC/HFSA guidelines for heart failure management, helping to prioritize recommendations based on cost-effectiveness and quality of life impact. It categorizes treatments into high, intermediate, and low economic value, aiding clinicians in…

Continue Reading2022 AHA/ACC/HFSA Heart Failure Management Guidelines – Value Statements

Stage D (Advanced) Heart Failure

Stage D (Advanced) Heart Failure This infographic summarizes the 2022 AHA/ACC/HFSA Heart Failure Guidelines for Stage D, or advanced heart failure. It highlights indicators of advanced heart failure, including persistent symptoms despite guideline-directed medical therapy (GDMT), and therapeutic considerations for patients, such as inotropes, mechanical circulatory support (MCS), and transplant.…

Continue ReadingStage D (Advanced) Heart Failure

Heart Failure and Pregnancy

Heart Failure & Pregnancy This infographic delves into how heart failure (HF) and pregnancy intersect, with a focus on the risks posed by prepregnancy cardiomyopathy and peripartum cardiomyopathy. Women with persistent left ventricular dysfunction (LVEF <50%) before pregnancy are at heightened risk for serious complications, including further LVEF deterioration, maternal…

Continue ReadingHeart Failure and Pregnancy

The Brockenbrough – Braunwald – Morrow Sign

The Brockenbrough-Braunwald-Morrow Sign: Understanding LVOT Obstruction in HCM This engaging CardioNerds illustration breaks down the Brockenbrough-Braunwald-Morrow sign, highlighting the hemodynamic dynamics in Hypertrophic Cardiomyopathy (HCM). The artwork uses characters to explain how premature ventricular contractions (PVCs) influence left ventricular outflow tract (LVOT) behavior. Key Highlights: Compensatory Pause After PVC: Prolonged…

Continue ReadingThe Brockenbrough – Braunwald – Morrow Sign

Inotropes

Inotropes This infographic provides a detailed breakdown of inotropes, including their mechanisms, clinical applications, and adverse effects. What are Inotropes? Inotropes increase the force of myocardial contraction. Their effects vary depending on which adrenergic receptors they activate: Alpha-1: Vasoconstriction Beta-1: Increases inotropy (contractility) and chronotropy (heart rate) Beta-2: Vasodilation Why…

Continue ReadingInotropes

Cardiac Manifestations of Systemic Sclerosis

Cardiac Manifestations of Systemic Sclerosis (SSc) This infographic explores the cardiac involvement in systemic sclerosis (SSc), a chronic autoimmune disease characterized by skin thickening, vasculopathy, internal organ fibrosis, and autoantibodies. Cardiac involvement is often subtle but can have significant morbidity and mortality. Key Points Often Underdiagnosed: Up to 70% of…

Continue ReadingCardiac Manifestations of Systemic Sclerosis

End of content

No more pages to load